What Is Non-Recourse Patient Financing and Why Are Health Systems Choosing It?
A CFO-Level Strategy for Reducing Patient Bad Debt and Protecting Revenue
Patient financial responsibility has become one of the most significant revenue risks in U.S. healthcare.
As high-deductible health plans, rising out-of-pocket costs, and growing patient balances place more pressure on both patients and providers, health systems are rethinking how they handle patient responsibility. Traditional collections are no longer working at scale. Patients facing $5,000, $8,000, or $15,000 out-of-pocket balances often do not engage with collectors. They defer care, disengage from their health system, and absorb the hit to their credit, while health systems absorb the uncollectible balance as bad debt.
Health systems across the U.S. are shifting toward a financial access approach. By offering patient-friendly payment options at the point of service, providers can convert potential bad debt into funded receivables before an account is ever sent to collections.
What Is Non-Recourse Patient Financing?
With non-recourse patient financing, a financial services company, not the health system, extends a line of credit directly to the patient. The financing company purchases the patient’s account receivable from the health system and assumes all credit risk associated with that account.
The differentiator of non-recourse financing is the absence of provider liability. If the patient fails to repay the financing company, the health system is not required to return any portion of the funds it received. The risk has been transferred completely and permanently from the health system to the financing company.
This is a direct contrast to recourse-based models, where the health system may retain contingent liability if patient accounts are not recovered.
Why Health Systems Are Choosing CURAEPay
CURAEPay’s non-recourse patient financing program is built to require minimal disruption to existing revenue cycle workflows and to provide a frictionless experience for the patient with one application and approval process for handling multiple patient balances over time.
Through CURAEPay, eligible patients may receive a provider-branded revolving line of credit of up to $10,000 for healthcare services. Once the patient’s account is financed by Curae, the health system receives full upfront payment for that balance within 48 hours.
After funding, the health system has no further financial obligation related to that account. Curae manages patient repayment, communications, customer service, and assumes all credit risk.
Reported Financial Impact
A health system using CURAEPay’s non-recourse patient financing solution reported:
• 25% increase in frontend collections
• 26% reduction in bad debt write-offs
• 200% increase in paid in full for balances of $1,500 or more
• Full upfront funding within 48 hours of each patient account financing
• High net promoter score associated with the provider’s brand and enhanced patient financial experience
Health systems using CURAEPay also report 2x to 3x improvement in patient collections for balances between $1,000 and $10,000 and a 22% reduction in bad debt.
What CFOs Should Evaluate
Not all non-recourse patient financing platforms are the same. CFOs and revenue cycle leaders should examine:
• Whether the program supports pre-service, post-service, current, and future balances
• Patient eligibility rates, including near-prime and below-prime patients
• Whether the model is truly non-recourse
• Funding timeline and balance-sheet treatment
• Regulatory standing under Regulation B and Regulation Z
• Ability to support a provider-branded patient experience
• Access to reliable capital and long-term platform stability
A platform approving up to 90%+ of applicants means more patients are served, and more potential bad debt is converted to funded receivables.
Read the Full Article
Learn why non-recourse patient financing is becoming a CFO-level priority for health systems and how CURAEPay helps providers protect revenue while expanding financial access to care.
Questions?
Gary Johnson
Chief Growth Officer, CURAE®
gary.johnson@curae.com
678-643-9801
Curae’s patient financing program is managed by Curae and its affiliated companies, offering and servicing consumer credit accounts issued by a federally regulated bank to patients. Net of Curae’s discount applied against the balance liquidated, based on each individual’s risk profile.
Actual results may vary and are dependent on implementing best practices, the patient population served, and local demographics.
Curae credit lines are issued by The Bank of Missouri, Perryville, MO.